EHN special editions
We're celebrating the 50th anniversary of the Health and Safety at Work Act and the Control of Pollution Act with two special editions of EHN available to all.
Weight-loss drug, semaglutide has been approved by MHRA as a preventative treatment for people with a BMI of 27 or over who suffer from established cardiovascular disease
EHN special editions
We're celebrating the 50th anniversary of the Health and Safety at Work Act and the Control of Pollution Act with two special editions of EHN available to all.